Renaissance Technologies BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is BMRN and the CUSIP is 09061G101. A total of 538 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Renaissance Technologies ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2022$63,109
+3.6%
744,471
+1.3%
0.09%
+23.6%
Q2 2022$60,890
+60.8%
734,763
+49.6%
0.07%
+63.6%
Q1 2022$37,869
-34.2%
491,171
-24.6%
0.04%
-38.9%
Q4 2021$57,521
+95.1%
651,060
+70.7%
0.07%
+89.5%
Q3 2021$29,484
+21.9%
381,471
+31.6%
0.04%
+26.7%
Q2 2021$24,195
-12.3%
289,971
-20.7%
0.03%
-11.8%
Q1 2021$27,604
+1610.3%
365,571
+1814.0%
0.03%
+1600.0%
Q1 2020$1,614
-90.6%
19,100
-90.6%
0.00%
-84.6%
Q4 2019$17,119
-54.3%
202,471
-63.6%
0.01%
-59.4%
Q3 2019$37,479
-18.6%
556,071
+3.5%
0.03%
-22.0%
Q2 2019$46,026
+60.9%
537,371
+66.9%
0.04%
+57.7%
Q1 2019$28,601
+670.9%
321,971
+639.0%
0.03%
+550.0%
Q4 2018$3,710
-81.5%
43,571
-78.9%
0.00%
-81.0%
Q3 2018$20,070
+53.1%
206,971
+31.8%
0.02%
+200.0%
Q2 2018$13,105
+25.7%
157,042
+22.1%
0.01%
-36.4%
Q1 2018$10,423
-55.3%
128,571
-50.8%
0.01%
-57.7%
Q4 2017$23,306
-21.8%
261,371
-18.4%
0.03%
-25.7%
Q3 2017$29,808
+158.7%
320,271
+152.4%
0.04%
+133.3%
Q2 2017$11,522
+253.3%
126,871
+222.2%
0.02%
+200.0%
Q4 2016$3,261
-70.1%
39,371
-70.2%
0.01%
-76.2%
Q1 2016$10,893
-46.3%
132,071
-31.8%
0.02%
-52.3%
Q4 2015$20,278
-26.7%
193,571
-26.3%
0.04%
-33.3%
Q3 2015$27,654
+63.5%
262,571
+112.3%
0.07%
+69.2%
Q2 2015$16,916
-14.1%
123,671
-55.8%
0.04%
-17.0%
Q4 2013$19,703280,0710.05%